Molecular biomarkers in multiple sclerosis
Abstract Multiple sclerosis (MS) is an inflammatory-neurodegenerative disease of the central nervous system presenting with significant inter- and intraindividual heterogeneity. However, the application of clinical and imaging biomarkers is currently not able to allow individual characterization and...
Main Authors: | Tjalf Ziemssen, Katja Akgün, Wolfgang Brück |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-12-01
|
Series: | Journal of Neuroinflammation |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12974-019-1674-2 |
Similar Items
-
The Cerebrospinal Fluid in Multiple Sclerosis
by: Florian Deisenhammer, et al.
Published: (2019-04-01) -
"AN ESTIMATION OF OLIGOCLONAL BANDS IN PATIENTS WITH MULTIPLE SCLEROSIS"
by: M. H. Harirchian, et al.
Published: (2004-09-01) -
"AN ESTIMATION OF OLIGOCLONAL BANDS IN PATIENTS WITH MULTIPLE SCLEROSIS"
by: M. H. Harirchian, et al.
Published: (2004-08-01) -
Cerebrospinal Fluid Analysis in Multiple Sclerosis Diagnosis: An Update
by: Bruna Lo Sasso, et al.
Published: (2019-06-01) -
The Role of Antibodies in the Pathogenesis of Multiple Sclerosis
by: Xiaoli Yu, et al.
Published: (2020-10-01)